Series A · AI & Machine Learning · Trieste, Italy · Founded 2016 · 20–30 employees
InSilicoTrials provides a cloud-based platform for computational modeling and AI-driven simulation to accelerate pharmaceutical and medical device development. The company helps reduce R&D costs by 40-60% and regulatory approval times from months to hours through virtual clinical trials and digital twins. Founded in 2016 and based in Trieste, Italy's science hub, the startup has raised €3 million in Series A funding led by United Ventures and collaborates with over 70 universities and research centers globally. The company works with the FDA and EMA to advance regulatory-grade simulation tools and has revenue of approximately €6 million.
No open roles listed right now.